BioGaia has signed an agreement with Beijing Keyuan Xinhai Pharmaceutical Company Ltd. for the exclusive rights to sell BioGaia's ProTectis baby drops and ProTectis and Gastrus tablets through the retail pharmacy channel in China from 2013.
The products will be sold under BioGaia's own brand.
Beijing Keyuan Xinhai Pharmaceutical Company Ltd. was founded in 1995. It is a large pharmaceutical company with business in several areas, such as hospital drug supply and sales of medical appliances, consumables and pharmaceuticals. The company is a wholly owned subsidiary of Shanghai Pharmaceuticals Holding Company Ltd.
Both the BioGaia ProTectis baby drops and the BioGaia ProTectis tablets contain BioGaia's patented and well researched probiotic strain Lactobacillus reuteri Protectis. Today BioGaia's finished products are available in around 60 countries. BioGaia Gastrus is a new product that is currently being investigated in patients with Helicobacter pylori infection.